Health News Roundup: Italy reports 24 new coronavirus deaths, 2,437 new cases; UK reports most COVID-19 cases in a day since mid-July and more


Following is a summary of current health news briefs.

U.S. administers 408.3 million doses of COVID-19 vaccines – CDC

The United States has administered 408,265,959 doses of COVID-19 vaccines as of Sunday morning, the Centers for Disease Control and Prevention said. The figures are up from the 407,446,961 vaccine doses the CDC said had gone into arms by Oct. 16.

Boeing workers stage protest near Seattle over U.S. vaccine mandate

Waving signs like “coercion is not consent,” and “stop the mandate,” some 200 Boeing Co employees and others staged a protest on Friday over the planemaker’s COVID-19 vaccine requirement for U.S. workers. Boeing said on Tuesday it will require https://www.reuters.com/business/aerospace-defense/boeing-will-require-its-125000-us-employees-be-vaccinated-against-covid-19-2021-10-12 its 125,000 U.S. employees to be vaccinated by Dec. 8 under an executive order issued by President Joe Biden for federal contractors.

Italy reports 24 new coronavirus deaths, 2,437 new cases

Italy reported 24 coronavirus-related deaths on Sunday, up from 14 the previous day, the health ministry said, while the daily tally of new infections fell to 2,437 from 2,983. Italy has registered 131,541 deaths linked to COVID-19 since the outbreak in February last year. It has the second highest toll in Europe behind Britain, and the ninth highest in the world.

Melbourne to ease world’s longest COVID-19 lockdowns as vaccinations rise

Melbourne, which has spent more time under COVID-19 lockdowns than any other city in the world, is set to lift its stay-at-home orders this week, officials said on Sunday. By Friday, when some curbs will be lifted, the Australian city of 5 million people will have been under six lockdowns totalling 262 days, or nearly nine months, since March 2020.

UK reports most COVID-19 cases in a day since mid-July

Britain on Sunday reported 45,140 new cases of COVID-19, the highest daily number since the middle of July, and 57 new deaths within 28 days of a positive test, according to official data.

Spain’s ‘Crying Room’ seeks to banish mental health taboo

“Enter and cry,” one sign tells visitors. “I too have anxiety,” glows another notice in pink. There are phones in one corner with the names of people you can call when you are feeling down, including a psychologist. Welcome to La Lloreria, or the Crying Room. Anyone can drop in at the project, housed in a building in central Madrid, which aims to remove the stigma in society attached to mental health, crying and seeking help.

UAE’s daily COVID-19 cases fall below 100

The United Arab Emirates on Sunday recorded a drop in daily COVID-19 cases to below 100 for the first time since the start of the outbreak last year as it hosts a huge world fair to which it hopes to attract millions of visits. The Health Ministry reported 99 new cases, down from a peak of nearly 4,000 a day in January. The UAE’s cumulative death toll stands at 2,120.

Russia’s reports record-high daily COVID-19 infections

Russia reported 34,303 cases of new coronavirus infections in the past 24 hours, a record-high number since the start of the pandemic, data from the state coronavirus task force showed on Sunday. It also reported 997 deaths from the disease, five fewer than the daily record-high of 1,002 reported the previous day.

Biogen trial of ALS drug fails main goal, but company says data are encouraging

A late-stage trial of Biogen Inc’s experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) failed to reach its main goal, but secondary measures and biomarkers showed favorable trends, the company said on Sunday. Biogen will engage with regulators and other stakeholders “to understand the meaningfulness of this data and potential paths forward,” Toby Ferguson, head of the neuromuscular development unit at Biogen, told Reuters. The company is treating trial patients in a follow-on study and recently launched a Phase 3 trial of the drug, tofersen, in patients who are not yet experiencing ALS symptoms.

Merck COVID-19 pill sparks calls for access for lower income countries

The plan to roll out Merck & Co’s promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say. For example, only about 5% of Africa’s population is immunized, creating an urgent need for therapeutics that could keep people out of hospitals. That compares with more than a 70% inoculation rate in most wealthy nations.

(With inputs from agencies.)



Source link

We will be happy to hear your thoughts

Leave a reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ozinize
Logo
Shopping cart